PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

McMaster University researchers find fever-reducing medications may aid spread of influenza

2014-01-22
(Press-News.org) Contact information: Veronica McGuire
vmcguir@mcmaster.ca
905-525-9140 ext. 22169
McMaster University
McMaster University researchers find fever-reducing medications may aid spread of influenza Hamilton, ON (Jan. 21, 2014) -- Contrary to popular belief, fever-reducing medication may inadvertently cause more harm than good.

New research from McMaster University has discovered that the widespread use of medications that contain fever-reducing drugs may lead to tens of thousands more influenza cases, and more than a thousand deaths attributable to influenza, each year across North America. These drugs include ibuprofen, acetaminophen and acetylsalicylic acid.

"When they have flu, people often take medication that reduces their fever. No-one likes to feel miserable, but it turns out that our comfort might be at the cost of infecting others," said lead author David Earn, an investigator with the Michael G. DeGroote Institute for Infectious Disease Research (IIDR) and professor of mathematics at McMaster University.

"Because fever can actually help lower the amount of virus in a sick person's body and reduce the chance of transmitting disease to others, taking drugs that reduce fever can increase transmission. We've discovered that this increase has significant effects when we scale up to the level of the whole population."

The study, published in the Proceedings of the Royal Society B today, was co-authored with McMaster professors Ben Bolker, of the departments of mathematics & statistics and biology and the IIDR, and Paul Andrews of the Department of Psychology, Neuroscience and Behaviour.

"People often take -- or give their kids -- fever-reducing drugs so they can go to work or school," Earn said. "They may think the risk of infecting others is lower because the fever is lower. In fact, the opposite may be true: the ill people may give off more virus because fever has been reduced."

The researchers assembled information from many sources, including experiments on human volunteers and on ferrets (which are the best animal model for human influenza). They then used a mathematical model to compute how the increase in the amount of virus given off by a single person taking fever-reducing drugs would increase the overall number of cases in a typical year, or in a year when a new strain of influenza caused a flu pandemic.

The bottom line is that fever suppression increases the number of annual cases by approximately five per cent, corresponding to more than 1,000 additional deaths from influenza in a typical year across North America.

"This research is important because it will help us understand how better to curb the spread of influenza," said David Price, professor and chair of family medicine for McMaster's Michael G. DeGroote School of Medicine.

The family physician agrees with the researchers' conclusions. "As always, Mother Nature knows best. Fever is a defence mechanism to protect ourselves and others. Fever-reducing medication should only be taken to take the edge off the discomfort, not to allow people to go out into the community when they should still stay home."

"People are often advised to take fever-reducing drugs and medical texts state that doing so is harmless," added Andrews. "This view needs to change."

The research findings echo previous research that has shown how the widespread use of medication can have unwanted effects on the transmission of disease. For example, it is now well accepted that the indiscriminate use of antibiotics has driven the emergence of life-threatening antibiotic resistant bacteria.

Bolker said: "Parents and health care professionals alike have focused on making their children or patients feel better by reducing fever, without being aware of potentially harmful side effects at the population level.

"Although we have put together the best available estimates for each parameter in our model, we have a long way to go before we can make concrete policy proposals.

"We need more experiments to determine precisely how much reducing fever increases viral shedding in humans, and to estimate how much more people spread disease because they are more active in the community when they alleviate their symptoms by taking medication."

### The study was supported by the Natural Sciences and Engineering Research Council of Canada and the Michael G. DeGroote Institute for Infectious Disease Research.

Note to Editors

A photo of the McMaster researchers can be found at: http://fhs.mcmaster.ca/media/fever/

For further information

Veronica McGuire
Media Relations
Faculty of Health Science
McMaster University
905-525-9140, ext. 22169
vmcguir@mcmaster.ca


ELSE PRESS RELEASES FROM THIS DATE:

Calcium absorption not the cause of evolution of milk digestion in Europeans

2014-01-22
Calcium absorption not the cause of evolution of milk digestion in Europeans Ancient DNA from early Iberian farmers shows that the wideheld evolutionary hypothesis of calcium absorption was not the only reason Europeans evolved milk tolerance. Most ...

How the genetic blueprints for limbs came from fish

2014-01-22
How the genetic blueprints for limbs came from fish A study led by Denis Duboule shows that these appendages have emerged during evolution by modernisation of a preexisting DNA structure The transition from water to land is one of the most fascinating enigmas ...

Exercising more, sitting less reduces heart failure risk in men

2014-01-22
Exercising more, sitting less reduces heart failure risk in men American Heart Association Rapid Access Journal Report Sitting for long periods increases heart failure risk in men, even for those who exercise regularly, according to new research published in ...

Wide variation found in quality of evidence used by FDA for approval of new drugs

2014-01-22
Wide variation found in quality of evidence used by FDA for approval of new drugs Clinical trials used by the Food and Drug Administration (FDA) to approve new drugs between 2005 and 2012 vary widely in their characteristics, according to a study in the January ...

Study examines reasons for delay, denial of new drugs by FDA

2014-01-22
Study examines reasons for delay, denial of new drugs by FDA Several potentially preventable deficiencies, including failure to select optimal drug doses and suitable outcome measures for a study, accounted for significant delays in the approval of new drugs ...

Biomarkers in blood show potential as early detection method of pancreatic cancer

2014-01-22
Biomarkers in blood show potential as early detection method of pancreatic cancer Researchers have identified diagnostic microRNA panels in whole blood that had the ability to distinguish, to some degree, patients with and without pancreatic cancer, according ...

Many CV devices approved by process that often does not require new clinical data

2014-01-22
Many CV devices approved by process that often does not require new clinical data Many cardiac implantable electronic device models currently in use were approved via a Food and Drug Administration review process in which the models were assumed safe and effective ...

Mediterranean diet associated with lower risk of peripheral artery disease

2014-01-22
Mediterranean diet associated with lower risk of peripheral artery disease A multicenter study that previously reported a reduction in heart attack and stroke with a Mediterranean diet supplemented with extra-virgin olive oil or with nuts now also reports a ...

Deaths higher for heart attack patients at night and weekends

2014-01-22
Deaths higher for heart attack patients at night and weekends Research: Off-hour presentation and outcomes in patients with acute myocardial infarction: systematic review and meta-analysis Mortality is higher, and emergency treatment takes longer, for ...

Long term exposure to air pollution linked to coronary events

2014-01-22
Long term exposure to air pollution linked to coronary events Association persists at levels of exposure below current European limits Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association ...

LAST 30 PRESS RELEASES:

A comprehensive review charts how psychiatry could finally diagnose what it actually treats

Thousands of genetic variants shape epilepsy risk, and most remain hidden

First comprehensive sex-specific atlas of GLP-1 in the mouse brain reveals why blockbuster weight-loss drugs may work differently in females and males

When rats run, their gut bacteria rewrite the chemical conversation with the brain

Movies reconstructed from mouse brain activity

Subglacial weathering may have slowed Earth's escape from snowball Earth

Simple test could transform time to endometriosis diagnosis

Why ‘being squeezed’ helps breast cancer cells to thrive

Mpox immune test validated during Rwandan outbreak

Scientists pinpoint protein shapes that track Alzheimer’s progression

Researchers achieve efficient bicarbonate-mediated integrated capture and electrolysis of carbon dioxide

Study reveals ancient needles and awls served many purposes

Key protein SYFO2 enables 'self-fertilization’ of leguminous plants

AI tool streamlines drug synthesis

Turning orchard waste into climate solutions: A simple method boosts biochar carbon storage

New ACP papers say health care must be more accessible and inclusive for patients and physicians with disabilities

Moisture powered materials could make cleaning CO₂ from air more efficient

Scientists identify the gatekeeper of retinal progenitor cell identity

American Indian and Alaska native peoples experience higher rates of fatal police violence in and around reservations

Research alert: Long-read genome sequencing uncovers new autism gene variants

Genetic mapping of Baltic Sea herring important for sustainable fishing

In the ocean’s marine ‘snow,’ a scientist seeks clues to future climate

Understanding how “marine snow” acts as a carbon sink

In search of the room temperature superconductor: international team formulates research agenda

Index provides flu risk for each state

Altered brain networks in newborns with congenital heart disease

Can people distinguish between AI-generated and human speech?

New robotic microfluidic platform brings ai to lipid nanoparticle design

COSMOS trial results show daily multivitamin use may slow biological aging

Immune cells play key role in regulating eye pressure linked to glaucoma

[Press-News.org] McMaster University researchers find fever-reducing medications may aid spread of influenza